4//SEC Filing
JOHNSON DAVID LEE 4
Accession 0000899243-22-030479
CIK 0001629137other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 7:00 PM ET
Size
15.1 KB
Accession
0000899243-22-030479
Insider Transaction Report
Form 4
JOHNSON DAVID LEE
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-09-01+2,208→ 58,487 total - Award
Common Stock
2022-08-31$25.37/sh+365$9,260→ 53,516 total - Tax Payment
Common Stock
2022-09-01$68.15/sh−2,103$143,319→ 56,384 total - Exercise/Conversion
Restricted Stock Units
2022-09-01−2,208→ 15,460 total→ Common Stock (2,208 underlying) - Exercise/Conversion
Common Stock
2022-09-01+2,763→ 56,279 total - Exercise/Conversion
Restricted Stock Units
2022-09-01−2,763→ 13,814 total→ Common Stock (2,763 underlying)
Footnotes (5)
- [F1]Shares acquired pursuant to the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F3]Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 4,971 shares of Common Stock underlying the Reporting Person's RSUs.
- [F4]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F5]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2022, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001733883
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 7:00 PM ET
- Size
- 15.1 KB